has been cited by the following article(s):
|
[1]
|
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
|
|
Spitzenberg… - Cell death …,
2023 |
|
|
|
|
[2]
|
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
|
|
Cancers,
2021 |
|
|
|
|
[3]
|
EVALUATING SOLUBLE AXL AS A BIOMARKER FOR GLIOBLASTOMA
|
|
2020 |
|
|
|
|
[4]
|
Growth arrest-specific 6 und Soluble Axl als Biomarker bei pulmonaler Hypertonie
|
|
2019 - Dissertation, Gieß en,
2019 |
|
|
|
|
[5]
|
Vitamin K Dependent Proteins in Kidney Disease
|
|
2019 |
|
|
|
|
[6]
|
Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma
|
|
2017 |
|
|
|
|
[7]
|
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
|
|
Cell Death & Disease,
2017 |
|
|
|
|
[8]
|
Role of Tyro3, Axl and Mer receptors and their ligands (Gas6 and Protein S) in patients with hepatocellular carcinoma
|
|
2017 |
|
|
|
|
[9]
|
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
|
|
Journal of hepatology,
2015 |
|
|
|
|
[1]
|
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
Cell Death Discovery,
2023
DOI:10.1038/s41420-023-01551-6
|
|
|
|
|
[2]
|
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
Cancers,
2021
DOI:10.3390/cancers13215448
|
|
|
|
|
[3]
|
Vitamin K Dependent Proteins in Kidney Disease
International Journal of Molecular Sciences,
2019
DOI:10.3390/ijms20071571
|
|
|
|
|
[4]
|
Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma
Journal of Cancer Therapy,
2017
DOI:10.4236/jct.2017.82010
|
|
|
|
|
[5]
|
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Cell Death and Disease,
2017
DOI:10.1038/cddis.2017.554
|
|
|
|
|
[6]
|
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
Journal of Hepatology,
2015
DOI:10.1016/j.jhep.2015.04.013
|
|
|
|